Cytokinetics (CYTK) Stock Price
$60.64 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
8
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Cytokinetics, AI stock picks, stock alerts and much more.
CYTK AI Stock Analysis
AI stock analysis for CYTK is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cytokinetics (CYTK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cytokinetics (CYTK) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cytokinetics (CYTK), currently trading at $60.64, will... Sign up to access price prediction.
About CYTK
-
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases.
-
Symbol
CYTK
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
7.3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.73 0.5% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.41 0.8% |
2 |
 |
Moderna MRNA |
$27.54 3.3% |
4 |
 |
Anavex Life Sciences AVXL |
$9.61 3.5% |
5 |
 |
BridgeBio Pharma BBIO |
$54.61 3.3% |
6 |
News
CYTK Alternative Data
Web Traffic
Cytokinetics receives an estimated 14441 monthly visitors to cytokinetics.com.
-
Web Traffic
14441
-
Change from Previous Month
0.4%
-
3 Month Change
4.2%
-
YoY Change
4.2%
Twitter Followers
Cytokinetics has 1,818 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
1818
-
Daily Change
0.1%
-
1 Month Change
0.5%
-
3 Month Change
2.1%
-
YoY Change
2.1%
Facebook Engagement
Cytokinetics has engaged 2 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
2
-
Daily Change
0%
-
1 Month Change
33.3%
-
3 Month Change
100%
-
YoY Change
100%
Youtube Subscribers
Cytokinetics has 513 subscribers on its main Youtube channel, up by 1% over the last month.
-
Youtube Subscribers
513
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
1.8%
-
YoY Change
1.8%
LinkedIn Followers
39,268 are following Cytokinetics on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
39268
-
Daily Change
0.1%
-
1 Month Change
2.1%
-
3 Month Change
7.3%
-
YoY Change
7.3%
Job Postings
Cytokinetics currenly has an estimated 39 open job postings, up by 34.5% over the last month.
-
Job Postings
39
-
Daily Change
2.6%
-
1 Month Change
34.5%
-
3 Month Change
68.8%
-
YoY Change
68.8%
LinkedIn Employees
According to LinkedIn, Cytokinetics has 644 employees, up by 0.2% over the last month.
-
LinkedIn Employees
644
-
Daily Change
0.9%
-
1 Month Change
0.2%
-
3 Month Change
5.1%
-
YoY Change
5.1%
Reddit Mentions
Cytokinetics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Cytokinetics is 44 out of 100 (neutral).
-
Business Outlook
44
-
Change from Previous Month
10.2%
-
3 Month Change
10.2%
-
YoY Change
10.2%
News Mentions
Cytokinetics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CYTK Financials
CYTK Key Metrics
-
Total Revenue
$16.9M
-
Net Income
-$150M
-
Earnings per Share
-$1.34
-
Free cash flow
-$66.9M
-
EBITDA
-$125M
-
EBITDA Ratio
-7.38719
-
Total Assets
$1.4B
CYTK 2-year Revenue & Income
CYTK 2-year Free Cash Flow
CYTK Technicals
CYTK SMA
CYTK RSI
FAQ
What's the current price of Cytokinetics (CYTK) Stock?
The price of an Cytokinetics (CYTK) share is $60.64.
What's the market cap of Cytokinetics?
The current market cap of Cytokinetics is 7.3B.
What are some stocks similar to Cytokinetics (CYTK) that investors often compare it to?
Cytokinetics (CYTK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Cytokinetics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cytokinetics' stock price to be around $60.31 in 2026. Starting from the current price of $60.64, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Cytokinetics (CYTK) Stock?
Cytokinetics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cytokinetics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.